Mohamed A. Mashahit

Half of Three Oral Antidiabetic Drugs as a Regimen for Treatment of Type 2 Diabetes Mellitus Patients in Low-income Populations

Mohamed A. Mashahit, Eman M. Ezzat & Ahmed A. Hammad · Journal of Advances in Medicine and Medical Research · 2017

There is a progressive increase in the number of patients developing type 2 diabetes mellitus (T2DM), worldwide. Several classes of antidiabetic drugs are available. Metformin is a biguanide with many pleiotropic effects in addition to decreasing hyperglycemia. Dipeptidyl-peptida...

Open access Research Article 10.9734/JAMMR/2017/37656

Vitamin D and Insulin Resistance in Metabolic Syndrome

Mohamed A. Mashahit & Eman M. Ezzat · Asian Journal of Medicine and Health · 2017

Poor vitamin D status is frequently linked with nearly all elements of the metabolic syndrome. There is insufficient evidence of beneficial effect to recommend vitamin D supplementation as a means of improving insulin resistance. The aim of this study was to determine the relatio...

Open access Research Article 10.9734/AJMAH/2017/36087

Visfatin Level in Diabetic and Non-diabetic Chronic Kidney Diseases

Samer S. Zekry, Maher A. Al Amir, Mohamed A. Mashahit, Hoiyda A. Abd El-Rasol & Ehab A. Hassan · Asian Journal of Medicine and Health · 2017

Introduction: Chronic kidney disease (CKD) has become a global public health threat. The irreversible nature of the disease, its association with significant morbidity and mortality as well as the cost of renal replacement therapy leads to a large burden for health care providers...

Open access Research Article 10.9734/AJMAH/2017/36085